Anti-thrombotic effect of a factor Xa inhibitor TAK-442 in a rabbit model of arteriovenous shunt thrombosis stimulated with tissue factor
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-thrombotic effect of a factor Xa inhibitor TAK-442 in a rabbit model of arteriovenous shunt thrombosis stimulated with tissue factor ; volume:11 ; number:1 ; day:30 ; month:10 ; year:2018 ; pages:1-4 ; date:12.2018
BMC Research Notes / Biomed Central; 11, Heft 1 (30.10.2018), 1-4, 12.2018
- Creator
-
Shinozawa, Emiko
Kawamura, Masaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-018-3886-4
- URN
-
urn:nbn:de:101:1-2018121822415837573997
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shinozawa, Emiko
- Kawamura, Masaki
- SpringerLink (Online service)
Other Objects (12)
Anti-thrombotic agents derived from snake venom proteins
Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Prognostic factors in thrombotic thrombocytopenic purpura
Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Roles of factor Xa beyond coagulation
Roles of factor Xa beyond coagulation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Novel oral anticoagulants: A new era in anti-thrombotic therapy
Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors
New Chromogenic Peptide Substrate for Factor Xa
Synthesis of Coagulation Factor Xa Inhibitor Apixaban
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Anti-thrombotic agents derived from snake venom proteins
Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Prognostic factors in thrombotic thrombocytopenic purpura
Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Roles of factor Xa beyond coagulation
Roles of factor Xa beyond coagulation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Novel oral anticoagulants: A new era in anti-thrombotic therapy
Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors
New Chromogenic Peptide Substrate for Factor Xa
Synthesis of Coagulation Factor Xa Inhibitor Apixaban
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Anti-thrombotic agents derived from snake venom proteins
Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Prognostic factors in thrombotic thrombocytopenic purpura
Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
Roles of factor Xa beyond coagulation
Roles of factor Xa beyond coagulation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Novel oral anticoagulants: A new era in anti-thrombotic therapy
Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors
New Chromogenic Peptide Substrate for Factor Xa
Synthesis of Coagulation Factor Xa Inhibitor Apixaban